Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression

Retrovirology

Volumn 11, Issue 1, 2014, Pages

  Rowan, Aileen G ^a   Suemori, Koichiro ^b   Fujiwara, Hiroshi ^b   Yasukawa, Masaki ^b   Tanaka, Yuetsu ^c   Taylor, Graham P ^a   Bangham, Charles ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

CTL; Cytotoxic lymphocyte response; Fas; HBZ; HLA; HTLV 1; ICAM 1; Retrovirus; Tax

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; EPITOPE; FAS ANTIGEN; HLA A ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; TAX PROTEIN; HBZ PROTEIN, HUMAN T-CELL LEUKEMIA VIRUS TYPE I; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 1; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; BINDING COMPETITION; CD4+ T LYMPHOCYTE; CELL KILLING; CELL SURFACE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PLASMID; PRIMARY CELL; PROTEIN EXPRESSION; PROTEIN PROCESSING; TAX+ CD4+ T CELL; UPREGULATION; VIRUS REACTIVATION; CYTOTOXICITY; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOLOGY; VIROLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 84924132601     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-014-0116-6     Document Type: Article

References (42)

1. ++T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000, 95:1386-1392.
2. Kattan T, MacNamara A, Rowan AG, Nose H, Mosley AJ, Tanaka Y, Taylor GP, Asquith B, Bangham CRM: The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol 2009, 182:5723-5729.
3. Asquith B, Mosley AJ, Barfield A, Marshall SEF, Heaps A, Goon P, Hanon E, Tanaka Y, Taylor GP, Bangham CRM: A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol 2005, 86(Pt 5):1515-1523.
4. Satou Y, Yasunaga J, Yoshida M, Matsuoka M: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 2006, 103:720-725.
5. Arnold J, Yamamoto B, Li M, Phipps AJ, Younis I, Lairmore MD, Green PL: Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 2006, 107:3976-3982.
6. Saito M, Matsuzaki T, Satou Y, Yasunaga J-I, Saito K, Arimura K, Matsuoka M, Ohara Y: In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 2009, 6:19.
7. Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, Berry C, Bushman FD, Taylor GP, Bangham CRM: The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 2011, 117:3113-3122.
8. Laydon DJ, Melamed A, Sim A, Gillet NA, Sim K, Darko S, Kroll JS, Douek DC, Price DA, Bangham CRM, Asquith B: Quantification of HTLV-1 clonality and TCR diversity. PLoS Comput Biol 2014, 10:e1003646.
9. Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CRM: Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog 2013, 9:e1003271.
10. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR: HLA-alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 1999, 96:3848-3853.
11. MacNamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K, Yasukawa M, Taylor G, Bangham CRM, Asquith B: HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog 2010, 6:e1001117.
12. ++ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis 2011, 203:529-536.
13. Cavanagh M-H, Landry S, Audet B, Arpin-André C, Hivin P, Paré M-E, Thête J, Wattel E, Marriott SJ, Mesnard J-M, Barbeau B: HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated. Retrovirology 2006, 3:15.
14. Murata K, Hayashibara T, Sugahara K, Uemura A, Yamaguchi T, Harasawa H, Hasegawa H, Tsuruda K, Okazaki T, Koji T, Miyanishi T, Yamada Y, Kamihira S: A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J Virol 2006, 80:2495-2505.
15. Rende F, Cavallari I, Corradin A, Silic-Benussi M, Toulza F, Toffolo GM, Tanaka Y, Jacobson S, Taylor GP, D'Agostino DM, Bangham CRM, Ciminale V: Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood 2011, 117:4855-4859.
16. Johnson JM, Nicot C, Fullen J, Ciminale V, Casareto L, Mulloy JC, Jacobson S, Franchini G: Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12 I protein. J Virol 2001, 75:6086-6094.
17. Baas EJ, van Santen HM, Kleijmeer MJ, Geuze HJ, Peters PJ, Ploegh HL: Peptide-induced stabilization and intracellular localization of empty HLA class I complexes. J Exp Med 1992, 176:147-156.
18. Hershkovitz O, Zilka A, Bar-Ilan A, Abutbul S, Davidson A, Mazzon M, Kümmerer BM, Monsoengo A, Jacobs M, Porgador A: Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. J Virol 2008, 82:7666-7676.
19. Van den Elsen PJ: Expression regulation of major histocompatibility complex class I and class II encoding genes. Front Immunol 2011, 2(October):48.
20. Fukudome K, Furuse M, Fukuhara N, Orita S, Imai T, Takagi S, Nagira M, Hinuma Y, Yoshie O: Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines. Int J Cancer 1992, 52:418-427.
21. Tanaka Y, Hayashi M, Takagi S, Yoshie O: Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax1 and Tax2 of human T-cell leukemia viruses. J Virol 1996, 70:8508-8517.
22. Owen S, Rudolph DL, Dezzutti CS, Shibata N, Naik S, Caughman SW, Lal RB: Transcriptional activation of the intercellular adhesion molecule 1 (CD54) gene by human T lymphotropic palindromic response element. AIDS Res Hum Retrovirus 1997, 13:1429-1438.
23. I . J Immunol 2006, 176:5463-5470.
24. Yamamoto A, Hara H, Kobayashi T: Induction of the expression of gag protein in HTLV-I infected lymphocytes by anti-ICAM 1 antibody in vitro. J Neurol Sci 1997, 151:121-126.
25. Nejmeddine M, Negi VS, Mukherjee S, Tanaka Y, Orth K, Taylor GP, Bangham CRM: HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood 2009, 114:1016-1025.
26. Barnard AL, Igakura T, Tanaka Y, Taylor GP, Bangham CRM: Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood 2005, 106:988-995.
27. Hanon E, Stinchcombe JC, Saito M, Asquith BE, Taylor GP, Tanaka Y, Weber JN, Griffiths GM, Bangham CRM: Fratricide among CD8+ T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 2000, 13:657-664.
28. Li D, Molldrem JJ, Ma Q: LFA-1 regulates CD8+ T cell activation via T cell receptor-mediated and LFA-1-mediated Erk1/2 signal pathways. J Biol Chem 2009, 284:21001-21010.
29. Wang H, Wei B, Bismuth G, Rudd CE: SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility. Proc Natl Acad Sci U S A 2009, 106:12436-12441.
30. Goldstein JS, Chen T, Gubina E, Pastor RW, Kozlowski S: ICAM-1 enhances MHC-peptide activation of CD8+ T cells without an organized immunological synapse. Eur J Immunol 2000, 30:3266-3270.
31. Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993, 5:625-630.
32. Saggioro D, Silic-Benussi M, Biasiotto R, D'Agostino DM, Ciminale V: Control of cell death pathways by HTLV-1 proteins. Front Biosci 2009, 14:3338-3351.
33. Tanaka-Nakanishi A, Yasunaga J, Takai K, Matsuoka M: HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization. Cancer Res 2014, 74:188-200.
34. Kongphanich A, Hieda M, Kurokawa K, Murata T, Kobayashi N: Overcoming the blockade at the upstream of caspase cascade in Fas-resistant HTLV-I-infected T cells by cycloheximide. Biochem Biophys Res Commun 2002, 294:714-718.
35. Krueger A, Fas SC, Giaisi M, Bleumink M, Merling A, Stumpf C, Baumann S, Holtkotte D, Bosch V, Krammer PH, Li-Weber M: HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood 2006, 107:3933-3939.
36. Bleumink M, Köhler R, Giaisi M, Proksch P, Krammer PH, Li-Weber M: Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression. Cell Death Differ 2011, 18:362-370.
37. Arai M, Kannagi M, Matsuoka M, Sato T, Yamamoto N, Fujii M: Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. AIDS Res Hum Retrovirus 1998, 14:261-267.
38. Kurihara K, Harashima N, Hanabuchi S, Masuda M, Utsunomiya A, Tanosaki R, Tomonaga M, Ohashi T, Hasegawa A, Masuda T, Okamura J, Tanaka Y, Kannagi M: Potential immunogenicity of adult T cell leukemia cells in vivo. Int J Cancer 2005, 114:257-267.
39. Apcher S, Millot G, Daskalogianni C, Scherl A, Manoury B, Fåhraeus R: Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway. Proc Natl Acad Sci U S A 2013, 110:17951-17956.
40. Suemori K, Fujiwara H, Ochi T, Ogawa T, Matsuoka M, Matsumoto T, Mesnard J-M, Yasukawa M: HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol 2009, 90(Pt 8):1806-1811.
41. Demontis M, Hilburn S, Taylor GP: Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1. AIDS Res Hum Retrovirus 2013, 29:359-364.
42. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CRM: HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 2012, 120:3488-3490.